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One of the oldest recognized, most common,
but least reported arthropod-transmitted zoonoses
(1,2), murine virus is caused by Rickettsia typhi,
formerly named R. mooseri, a gram-negative
obligate intracellular bacterium (1,2). The main
vector of murine typhus is the rat flea Xenopsylla
cheopis, which maintains R. typhi in rodents.
Flea bites and contamination of excoriated skin
or the respiratory tract with infected flea feces
are the major sources of human infection
throughout the world (2). The classic reservoir
and vector are the rat and rat flea, respectively
(2); however, the role of cat fleas and opossums in
maintaining this microorganism has been
suggested in some areas of the United States
where rats and rat fleas are absent (2,3).
Although murine typhus has a worldwide
distribution, it is often unrecognized, and
documented cases are rarely reported, particu-
larly in tropical countries. Three recent cases of
murine typhus in 2 months in patients returning
to Europe from Indonesia indicate that murine
typhus should be considered a possible cause of
imported fever from Indonesia.
Case 1
In October 1997, a 29-year-old man living in
France was hospitalized with a 2-day history of
fever. On admission, his temperature was 40°C
and his pulse, at 70/min, was dissociated. No
signs of eruption or other abnormalities were
observed. The patient had returned from a 3-week
trip to Bali, Indonesia, 2 weeks before his
hospitalization but reported no arthropod bites
during his trip. Increases of alanine aminotrans-
ferase (110 U/L), aspartate aminotransferase
(120 U/L), lactate dehydrogenase (1000 U/L) and
reactive protein C (130 mg/L) associated with a
low white blood cell count were noted. Repeated
blood smears did not disclose any malaria
parasites. The patient received a 21-day treatment
with doxycycline plus rifampin and became
afebrile on day 3. He was discharged from the
hospital and remained well. An indirect immuno-
fluorescence assay (IFA) for antibodies reactive
with R. typhi antigens (4) showed raised levels of
immunoglobulin (Ig) M (1:512) and IgG (1:256).
Case 2
In November 1997, a 28-year-old man living
in France was hospitalized with a 6-day history
of fever. On admission, he had a low-grade fever
(38°C). Physical examination found no abnor-
malities except for a few skin ulcerations of the
inguinal area. The patient had returned from Bali
3 weeks before his hospitalization but reported no
arthropod bites during his trip. Biologic findings
were unremarkable. Blood smears did not disclose
malaria parasites. The blood cell count, hemoglo-
bin level, and blood chemistry values were within
normal limits. Serologic testing for antibodies
reactive with R. typhi antigens showed raised
levels of IgM (1:512) and IgG (1:256).
Case 3
The third patient, a 28-year-old man from
Belgium, became acutely ill during a trip to
Indonesia (Bali, Lava, Lombok), with a fever
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(40°C), shivers, diffuse myalgia, but no rash. He
was treated in Indonesia with amoxicillin,
followed by cefuroxim-axetil (500 mg twice a day
for 10 days), without success. The patient
recalled multiple insect bites during his trip.
Clinical examination on arrival in Belgium
showed severe disease with bilateral conjunctivi-
tis and splenomegaly, but no adenopathies.
Biologic findings were unremarkable except raised
levels of alanine aminotransferase (681 U/L),
aspartate aminotransferase (659 U/L), and
reactive protein C (17 mg/L). Analysis of the
cerebrospinal fluid showed 20 leukocytes/ml with
75% polymorphonuclear cells. Repeated blood
smears did not disclose any parasites. The patient
received empirical treatment with quinine,
doxycycline, and a quinolone to treat suspected
malaria or salmonellosis. The fever rapidly
resolved, and the patient recovered. Serologic
testing with IFA was positive for R. typhi (IgG,
512; IgM, 1024). Antibodies to R. typhi were also
detected in the cerebrospinal fluid (IgM, 2).
All patients exhibited serologic cross-
reactions (low titers) with R. prowazekii, the
agent of epidemic typhus, and R. conorii, the
agent of Mediterranean spotted fever (Table;1,4).
Serologic findings were completed by cross-
absorption. When absorption was performed
with R. typhi, homologous and heterologous
antibodies disappeared, but when absorption
was performed with R. prowazekii, only
homologous antibodies disappeared; therefore,
murine typhus was diagnosed as the cause of
illness in the three patients (4).
Murine typhus is a mild disease with
nonspecific signs (1). The incubation period is 7
to 14 days. The classic triad of fever, headache,
and skin rash is observed in fewer than 15% of
cases (5). While fever and headache are frequent,
a rash occurs in only half of the patients and is
often transient or unimpressive. This is
illustrated in these three cases, where no rash
was noted. Arthralgia, myalgia, or respiratory
and gastrointestinal symptoms are frequent (5).
Leukocytosis and mild leukopenia, anemia, and
thrombopenia occur frequently; hyponatremia,
hypoalbuminemia, hepatic abnormalities, or
renal dysfunction may occur (5). Fewer than half
of the patients report exposure to fleas or flea
hosts. Of the cases reported here, only one
involved insect bites. Untreated patients may
have fever and symptoms for 7 to 14 days and
then rapidly convalesce. The treatment of choice
is antibiotic therapy with tetracyclines. A single
200-mg dose of oral doxycycline usually leads to
defervescence during the first 72 hours (6).
Like our patients, most murine typhus
patients may have isolated fever and nonspecific
biologic abnormalities. Diagnosis may be missed
because the rash, the hallmark of rickettsial
diseases, is absent (1). For example, in a recent
review in the United States, 22 different
diagnoses were proposed for 80 patients with
murine typhus (5). Consequently, the diagnosis
of the disease is based on serologic testing. The
reference method is immunofluorescence; how-
ever, a latex test, a dot blot enzyme-linked
immunosorbent assay, and an immunoperoxydase
assay have also been described (4). The fact that
travel-associated cases of murine typhus have been
identified and may represent a source of imported
fever indicates that serologic testing should be
considered in febrile patients returning from
disease-endemic areas (Figure).
Table. Immunofluorescence testing for antibodies to Rickettsia typhi (Wilmington), R. prowazekii (Breinl), R.
conorii (Moroccan), and Orientia tsutsugamushi (Kato, Gilliam, Karp, Kawazaki) in febrile patients returning from
Indonesia
Titer (IgG/IgM)
Antigens R. typhi R. prowazekii R. conorii O. tsutsugamushi
Patient 1
  Acute serum    512/256 128/128 <16/128 <16/<16
  Convalescent serum    512/64 128/32 <16/<16 <16/<16
Patient 2
  Acute serum    256/512 128/512 <16/128 <16/<16
  Convalescent serum    256/512 <16/<16 <16/64 <16/<16
Patient 3
  Acute serum   512/1024 256/2048 <16/64 <16/<16
  Convalescent serum 1024/1024 512/1024 <16/32 <16/<16679 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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Tissot-Dupont et al. recently reported that
the prevalence of antibodies against R. typhi in
humans in Africa was higher in coastal areas
where rats are prevalent (Figure; 7). Other
seroepidemiologic studies demonstrated sub-
stantial seroprevalence in Asia (Thailand,
Vietnam, Japan, Indonesia, China), Europe
(Croatia, Greece), and Australia (6,8). Cases
have recently been reported in Greece, Spain,
Portugal, Israel, and Thailand (6). The disease
is known to be endemic in the United States
(particularly California, Hawaii, and Texas)
and Mexico (6). Some authors have reported
the disease in Rumania, Yugoslavia, Albania,
Italy, areas around the Caspian Sea, in
Kuwait, Latin America (Venezuela, Argentina,
Brazil, Chile, Ecuador, Panama, Guatemala,
Puerto Rico), and French Guyana (9). However,
serologic cross-reactivity may occur between
R. typhi and R. prowazekii, the agent of
epidemic typhus (1,4). Epidemic typhus, trans-
mitted by body lice, occurs more frequently in
cool areas where clothes are infrequently
changed and particularly during human con-
flicts (1). The disease is prevalent in countries at
high altitudes in Central America or Africa
(10,14); interpretation of serologic results in
these countries has at times been difficult (7,10).
However, cross-absorption is a useful technique
for identifying the infecting rickettsia to species
level as reported in the present cases (4).
Cases of murine typhus have been reported in
travelers returning from India, Nepal, Morocco,
Canary Islands, Spain, and Africa (6,11-13).
Although a case of murine typhus was reported in
a patient after a trip to Malaysia and Indonesia
(11), the cases reported here are the first
serologically documented cases clearly imported
from Indonesia. In Malang, East Java, humans are
highly exposed to R. typhi, and murine typhus
appears to be endemic in the region (8).
Fever is a common problem in patients
returning from travel abroad. Although malaria
is often suspected, rickettsial diseases (including
murine typhus) are generally not. Our cases
indicate that murine typhus should be consid-
ered in the diagnosis of febrile illness in travelers
returning from disease-endemic areas, particu-
larly if fever is present and blood smears show no
malaria parasites. Rickettsial diseases were
recently cited as the third most frequent cause of
imported fever in Switzerland (12). On the basis
of this study and two previous reports from
France (13) and the United States (11), murine
typhus is a frequently imported rickettsial
disease. Increased development of tourism and
travel to tropical countries should lead to an
increase in the documentation of cases.
Figure. Areas in which murine typhus poses a risk according to seroepidemiologic studies, case series, or
imported cases in travelers (1,2,6-13).680 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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